Depomed Inc (DEPO.OQ)

DEPO.OQ on NASDAQ Stock Exchange Global Select Market

14.99USD
3:41pm EDT
Price Change (% chg)

$-0.04 (-0.27%)
Prev Close
$15.03
Open
$14.96
Day's High
$15.23
Day's Low
$14.69
Volume
188,726
Avg. Vol
405,703
52-wk High
$15.51
52-wk Low
$6.95

DEPO.OQ

Chart for DEPO.OQ

About

Depomed, Inc. (Depomed) is a specialty pharmaceutical company initially focused on neurology, pain and other diseases of the central nervous system. In January 2011, the United States Food and Drug Administration (FDA) approved Gralise (gabapentin) once-daily tablets for the management of postherpetic neuralgia. The Company is... (more)

Overall

Beta: 1.54
Market Cap (Mil.): $878.90
Shares Outstanding (Mil.): 58.48
Dividend: --
Yield (%): --

Financials

  DEPO.OQ Industry Sector
P/E (TTM): 11.22 33.02 33.86
EPS (TTM): 1.34 -- --
ROI: 35.13 18.15 17.39
ROE: 60.25 18.85 18.25
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks